Want Better Clinical Trial Design? Get Early Patient Input, Says FDA
Executive Summary
A new guidance document from the US regulatory agency reasons that getting early feedback from patient advocates in the trial-design process could improve enrollment, trial completion and data quality.
You may also be interested in...
FDA Guidance Directs Researchers On Use Of Patient Advocates
A new guidance document from the US agency offers advice on how sponsors can use patient advocates to improve and streamline device clinical trials.
Patients Want Industry To Minimize Burdens, Augment Comforts Of Device Trial Participation
Patients and patient advocacy groups at the US FDA's inaugural Patient Engagement Advisory Committee meeting said they need sponsors to minimize the burdens and augment the comforts of trial participation, and get reports on outcomes along the way. Meanwhile, industry groups worried about revealing too much confidential business information, and biasing trial outcomes.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.